Mediaboss Marketing

Donald Trump will leave the White House without any major drug pricing plan to his name.

A federal judge on Wednesday agreed to issue a temporary restraining order against Trumps controversial most favored nation plan, which Trump tried to push through in an executive order. The plan would have limited Medicare reimbursements to what drug companies are paid in other affluent nations which is currently far less than the premiums available in the US.

The plan had been pushed through the process in an attempt to make it effective New Years day. With the restraining order, however, its unlikely to ever see the light of day.

PhRMA and a whole phalanx of industry groups like the AHA who sought the order were prepared to fight tooth and nail against the proposal. And come January 20, all the players will reassess a debate that has run on for years as Joe Biden is sworn in.

The only certain thing about all this: The debate over drug pricing shows no sign of ending anytime soon.

Trump tried to get this to fly through an interim final rule, which would have circumvented the usual discussion period.

In a statement, PhRMA general counsel James Stansel lambasted the policy and the procedure.

The Most Favored Nation Interim Final Rule is bad policy that is contrary to law and that the administration expressly admits will disrupt patients access to medicines. By pushing through a nationwide, mandatory policy change, the administration is essentially rewriting the Medicare statute. It is circumventing Congress entirely, ignoring the roles assigned to the executive and legislative branches.

Originally posted here:
A federal judge blocks Donald Trump's 'most favored nation' drug pricing plan as the lease runs out on the White House - Endpoints News